EP 3972652 A1 20220330 - ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THERAPY
Title (en)
ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THERAPY
Title (de)
ANTIKÖRPER-WIRKSTOFF-KONJUGATE UND IHRE VERWENDUNG IN DER THERAPIE
Title (fr)
CONJUGUES ANTICORPS-MEDICAMENT ET LEUR UTILISATION EN THERAPIE
Publication
Application
Priority
- FR 1905253 A 20190520
- FR 2020050833 W 20200519
Abstract (en)
[origin: WO2020234541A1] The invention relates to cytotoxic conjugates and antibody-drug conjugates, and to their use in therapy, in particular for treating HER2+ cancers.
IPC 8 full level
A61K 47/68 (2017.01); A61P 35/00 (2006.01)
CPC (source: CN EP US)
A61K 31/337 (2013.01 - US); A61K 31/4196 (2013.01 - US); A61K 31/675 (2013.01 - US); A61K 31/704 (2013.01 - US); A61K 39/3955 (2013.01 - US); A61K 47/6803 (2017.08 - CN EP); A61K 47/6817 (2017.08 - US); A61K 47/6849 (2017.08 - CN EP); A61K 47/6851 (2017.08 - CN EP); A61K 47/6855 (2017.08 - US); A61K 47/6889 (2017.08 - CN EP); A61P 35/00 (2018.01 - CN EP US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2020234541 A1 20201126; CA 3138498 A1 20201126; CN 114173825 A 20220311; EP 3972652 A1 20220330; FR 3096259 A1 20201127; FR 3096259 B1 20231215; JP 2022533854 A 20220726; US 2023102207 A1 20230330
DOCDB simple family (application)
FR 2020050833 W 20200519; CA 3138498 A 20200519; CN 202080050751 A 20200519; EP 20739429 A 20200519; FR 1905253 A 20190520; JP 2021569901 A 20200519; US 202017612351 A 20200519